BALAXI PHARMACEUTICALS LIMITED

Ask AI

Key metrics

Price as of 2026-04-20

Stock price
₹26.67
Market cap
147 Cr
Stock P/E
103.9
P/B
0.59

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Only consolidated filings are available for this company — standalone cannot be selected.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales66 Cr121 Cr181 Cr241 Cr66 Cr143 Cr73 Cr76 Cr71 Cr56 Cr73 Cr71 Cr
Operating expenses (approx.)105 Cr143 Cr188 Cr236 Cr57 Cr128 Cr65 Cr65 Cr68 Cr53 Cr69 Cr68 Cr
EBITDA-39 Cr-22 Cr-7 Cr6 Cr8 Cr15 Cr8 Cr11 Cr2 Cr3 Cr3 Cr3 Cr
OPM %-58.9%-18.4%-3.8%2.4%12.6%10.3%10.8%14.2%3.4%4.9%4.4%4.3%
Other income-1 Cr-0.73 Cr-0.86 Cr-3 Cr-2 Cr-6 Cr4 Cr-2 Cr-2 Cr2 Cr0.10 Cr3 Cr
Interest0.29 Cr0.66 Cr1 Cr2 Cr0.37 Cr0.82 Cr1 Cr0.73 Cr1 Cr0.89 Cr1 Cr0.99 Cr
Depreciation0.29 Cr0.95 Cr1 Cr2 Cr0.49 Cr0.95 Cr0.48 Cr0.46 Cr0.46 Cr0.48 Cr0.56 Cr0.65 Cr
Profit before tax-39 Cr-24 Cr-9 Cr2 Cr7 Cr13 Cr6 Cr10 Cr0.90 Cr1 Cr2 Cr1 Cr
Tax %-4.9%-13.3%-40.5%218.4%12.1%14.4%11.6%10.6%67.9%84.8%81.1%56.3%
Net profit-41 Cr-27 Cr-13 Cr-2 Cr6 Cr11 Cr5 Cr9 Cr0.29 Cr0.21 Cr0.30 Cr0.61 Cr
EPS (₹)₹-40.49₹-26.33₹-13.03₹-2.32₹1.17₹2.01₹0.97₹1.56₹0.05₹0.04₹0.06₹0.11

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2022Mar 2025Mar 2026TTM
Sales279 Cr293 Cr270 CrSign in for TTM
Operating expenses (approx.)224 Cr259 Cr259 CrSign in for TTM
EBITDA55 Cr33 Cr11 CrSign in for TTM
OPM %19.7%11.5%4.2%Sign in for TTM
Other income5 Cr-4 Cr3 CrSign in for TTM
Interest0.14 Cr3 Cr4 CrSign in for TTM
Depreciation0.51 Cr2 Cr2 CrSign in for TTM
Profit before tax55 Cr29 Cr5 CrSign in for TTM
Tax %12.6%12.6%73.2%Sign in for TTM
Net profit48 Cr25 Cr1 CrSign in for TTM
EPS (₹)₹47.66₹4.54₹0.26Sign in for TTM
Dividend payout %0.0%0.0%0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2022Mar 2025Mar 2026
Equity capital10 Cr11 Cr11 Cr
Reserves103 Cr221 Cr238 Cr
Borrowings—30 Cr33 Cr
Other liabilities—48 Cr55 Cr
Total liabilities—310 Cr337 Cr
Fixed assets (net)—14 Cr49 Cr
CWIP—22 Cr—
Investments—0.0000 Cr0.0000 Cr
Other assets—246 Cr252 Cr
Total assets—310 Cr337 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2022Mar 2025Mar 2026
Cash from operating activity34 Cr-35 Cr-5 Cr
Cash from investing-28 Cr-22 Cr-21 Cr
Cash from financing-0.16 Cr34 Cr0.44 Cr
Net cash flow6 Cr-23 Cr-25 Cr
Free cash flow (OCF − Capex)29 Cr-36 Cr-19 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2022Mar 2025Mar 2026
ROCE %48.3%12.1%3.3%
ROE %0.0%10.8%0.6%
Debtor days———
Inventory days—172201
Days payable———
Cash conversion cycle—172201
Debt / equity0.000.130.13
Current ratio—4.456.14
Net debt / EBITDA0.00-0.271.66